Urogen Pharma Ltd
NASDAQ:URGN

Watchlist Manager
Urogen Pharma Ltd Logo
Urogen Pharma Ltd
NASDAQ:URGN
Watchlist
Price: 10.71 USD 0.66% Market Closed
Market Cap: 452m USD
Have any thoughts about
Urogen Pharma Ltd?
Write Note

EV/OCF
Enterprise Value to OCF

-3.3
Current
-3.4
Median
5.9
Industry
Higher than median
Lower than industry value

Enterprise Value to Operating Cash Flow (EV/OCF) ratio is a valuation multiple that measures the value of a company, debt included, to the operating cash flow it generates.

EV/OCF
-3.3
=
Enterprise Value
321.5m USD
/
Operating Cash Flow
-96.1m USD
All Countries
Close
Market Cap EV/OCF
IL
Urogen Pharma Ltd
NASDAQ:URGN
449.3m USD -3.3
FR
Pharnext SCA
OTC:PNEXF
6T USD -239 691.7
US
Abbvie Inc
NYSE:ABBV
315.2B USD 22.2
US
Amgen Inc
NASDAQ:AMGN
141.9B USD 26.1
US
Gilead Sciences Inc
NASDAQ:GILD
116.4B USD 11.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
104.5B USD -114.8
US
Epizyme Inc
F:EPE
94.1B EUR -469.8
AU
CSL Ltd
ASX:CSL
135.7B AUD 34.2
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
78.7B USD 16.9
US
Seagen Inc
F:SGT
39.3B EUR -73.5
NL
argenx SE
XBRU:ARGX
36B EUR -132.5
 
IL
Urogen Pharma Ltd
NASDAQ:URGN
Average EV/OCF: 22.1
Negative Multiple: -3.3
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -239 691.7
US
Abbvie Inc
NYSE:ABBV
22.2
US
Amgen Inc
NASDAQ:AMGN
26.1
US
Gilead Sciences Inc
NASDAQ:GILD
11.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -114.8
US
E
Epizyme Inc
F:EPE
Negative Multiple: -469.8
AU
CSL Ltd
ASX:CSL
34.2
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.9
US
S
Seagen Inc
F:SGT
Negative Multiple: -73.5
NL
argenx SE
XBRU:ARGX
Negative Multiple: -132.5

EV/OCF Forward Multiples

Forward EV/OCF multiple is a version of the EV/OCF ratio that uses forecasted operating cash flow for the EV/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/OCF
N/A
2-Years Forward
EV/OCF
N/A
3-Years Forward
EV/OCF
N/A

See Also

Discover More